U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One): |_| Form 10-K and Form 10-KSB |_| Form 20-F |_| Form 11-K
|X| Form 10-Q and Form 10-QSB |_| Form N-SAR
For Period Ended: September 30, 2006
|_| Transition Report on Form 10-K
|_| Transition Report on Form 20-F
|_| Transition Report on Form 11-K
|_| Transition Report on Form 10-Q
|_| Transition Report on Form N-SAR
For the Transition Period Ended:
================================================================================
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
VERIFIED ANY INFORMATION CONTAINED HEREIN.
================================================================================
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
----------------------------------------------------
PART I - REGISTRANT INFORMATION
NUWAY MEDICAL INC.
----------------------------------------------------
Full Name of Registrant
----------------------------------------------------
Former Name if Applicable
2603 MAIN STREET, SUITE 1155
----------------------------------------------------
Address of Principal Executive
Office (Street and Number)
IRVINE, CA 92614
----------------------------------------------------
City, State and Zip Code
----------------------------------------------------
PART II - RULES 12b-25(b) AND (c)
----------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
|X| (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense.
|X| (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed
on or before the fifteenth calendar day following the prescribed due date;
or the subject quarterly report or transition report on Form 10-Q, or
portion thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
|_| (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
----------------------------------------------------
PART III - NARRATIVE
----------------------------------------------------
State below in reasonable detail the reasons why Form 10-K and Form
10-KSB, 20-F, 11-K, Form 10-Q and Form 10-QSB, N-SAR, or the transition report
or portion thereof could not be filed within the prescribed period. (Attach
Extra Sheets if Needed)
The Company is unable to file its report on Form 10-QSB primarily because
of management's decision to reclassify certain expenses in the current period
and the three-and six- month periods ended June 30, 2006, that had previously
been allocated to selling, general and administrative expenses, between research
and development expenses and selling, general and administrative expenses. These
changes and certain additional changes could not be completed without undue
burden or expense to the Company because of its small size and limited
resources. The Company intends to amend its Form 10-QSB for the period ended
June 30, 2006 and file its Form 10-QSB for the current period, on or before
November 20, 2006.
----------------------------------------------------
PART IV - OTHER INFORMATION
----------------------------------------------------
(1) Name and telephone number of person to contact to this notification
John R. Browning 949 270-7202
---------------------------------- ----------- ------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months (or for such shorter) period that the
registrant was required to file such reports) been filed? If answer is no,
identify report(s).
|X| Yes |_| No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
|_| Yes |X| No
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
================================================================================
NUWAY MEDICAL, INC.
================================================================================
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: November 14, 2006 By: /s/Dennis Calvert
---------------------- -------------------------
Name: Dennis Calvert
Title: President